Massively parallel signature sequencing is a sequencing-based method that provides quantitative gene expression data for nearly all transcripts in a particular ribonucleic acid sample. Although the sequencing technology is practiced as a service by a California-based company, we have developed methods for the handling and analysis of these data. This chapter describes the steps involved in obtaining data from massively parallel signature sequencing, aligning the signatures to genomic sequence, identifying novel transcripts, and performing quantitative analyses of genes expressed under conditions such as disease treatments.